Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer
Early detection and discovery of new therapeutic targets are urgently needed to improve the breast cancer treatment outcome. Here we conducted an official clinical trial with cross-validation to corroborate human plasma Hsp90α as a novel breast cancer biomarker. Importantly, similar results were not...
Main Authors: | Qiaoyun Hou, Shuohua Chen, Qi An, Boya Li, Yan Fu, Yongzhang Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/14/7747 |
Similar Items
-
Cytosolic Hsp90 Isoform-Specific Functions and Clinical Significance
by: Samarpan Maiti, et al.
Published: (2022-08-01) -
Analysis of the prognostic, diagnostic and immunological role of HSP90α in malignant tumors
by: Zhimin Yuan, et al.
Published: (2022-09-01) -
The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep
by: Cheng Chang, et al.
Published: (2023-01-01) -
Decreased Expression of Heat Shock Protein HSP90α after Exposure to Doxorubicin in Breast Cancer Cell Lines (MCF-7 and MDA-MB-231)
by: Fereshte Jokar, et al.
Published: (2017-02-01) -
Metformin Inhibits Tumor Metastasis through Suppressing Hsp90α Secretion in an AMPKα1-PKCγ Dependent Manner
by: Yuanchao Gong, et al.
Published: (2020-01-01)